Helen Colquhoun

Title: Helen Colquhoun: Innovator in Neuroactive Steroids

Introduction

Helen Colquhoun is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of neuroactive steroids, focusing on their therapeutic applications. With a total of 3 patents, her work has the potential to impact the treatment of various neurological disorders.

Latest Patents

Colquhoun's latest patents include innovative methods for treating tremors, depression, and anxiety disorders using neuroactive steroids. These patents describe methods that involve administering neuroactive steroids or compositions containing them, such as pregnanolone, allopregnanolone, alphadalone, ganaxolone, or alphaxolone, to human subjects suffering from these conditions. Her research aims to provide new avenues for treatment, particularly for essential tremor and post-partum depression.

Career Highlights

Helen Colquhoun is currently associated with Sage Therapeutics, Inc., where she continues her research and development in neuroactive steroids. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative therapies.

Collaborations

Colquhoun collaborates with Stephen Jay Kanes, further enhancing her research efforts and contributing to the scientific community.

Conclusion

Helen Colquhoun's contributions to the field of neuroactive steroids exemplify her dedication to innovation in medical treatments. Her patents and ongoing research hold promise for improving the lives of individuals affected by neurological disorders.